NCT01316679已完成不适用
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 87
研究概览
简要总结
Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Ability and willingness to provide written informed consent
- •Must be between 18-90 years of age at the time of consent
- •Ability to provide urine specimen at protocol-defined timepoints
- •Must have treatment interventions planned that are directly related to liver disease (excluding those assigned to group 3-Controls)
排除标准
- •Suspected inability, e.g. unwillingness to comply with study procedures or unwillingness to provide written consent
研究者
David L Gorden
Professor
Vanderbilt University Medical Center
相似试验
尚未招募
Unknown
Role of urine tests in knowing the type of kidney damage occurring in liver disease patientsCTRI/2023/11/059816Deep Patel
已完成
不适用
Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.Overactive BladderNCT01739946Michael Chancellor, MD30
已完成
不适用
Determination of the optimal biomarkers in urine and hair after oral and dermal pesticide exposure in order to quantify the pesticide exposure*NL-OMON43439Radboud Universitair Medisch Centrum36
已完成
不适用
Urine Proteome of Surgical Patients and Healthy VolunteersRenal Cell CancerNCT01538823Washington University School of Medicine664
尚未招募
不适用
RINE BIOMARKER SCREENING FOR PROSTATE CANCERCTRI/2021/09/036323Medicametrix